BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10150147)

  • 1. Donor hemapheresis in France at the start of 1992.
    Coffe C; Norol F
    Transfus Sci; 1993 Apr; 14(2):163-4. PubMed ID: 10150147
    [No Abstract]   [Full Text] [Related]  

  • 2. High efficiency of CD34+ selection by removal of platelets from the apheresis product.
    Schreiner T; Maccari B; Erne E; Bischof C; Wiesneth M
    Beitr Infusionsther Transfusionsmed; 1997; 34():144-9. PubMed ID: 9356665
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of thrombocytapheresis and leukocytapheresis in healthy donors].
    Höcker P; Wagner A; Puffer G; Michl U
    Beitr Infusionther Klin Ernahr; 1987; 18():205-9. PubMed ID: 3439974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the centrifugation speed on the sedimentation behavior of thrombocytes in the CS-3000 Cell Separator (Fenwal)].
    Brauer H; Aulmann HM; Stangel W
    Beitr Infusionther Klin Ernahr; 1987; 18():219-22. PubMed ID: 3439977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the side effects and donor safety in preparatory cell collection using the cell separators CS 3,000 and V 50].
    Taborski U; Müller N
    Infusionstherapie; 1989 Aug; 16(4):186-8. PubMed ID: 2807566
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preparation of leukocyte and thrombocyte concentrates using the Haemonetics model 30 blood cell separator].
    Fehérvízyová E; Hrubisko M; Danihelová E; Sviteková K
    Vnitr Lek; 1986 Aug; 32(8):784-9. PubMed ID: 3765416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of the Fenwal CS-3000 automatic blood cell separator for cytopheresis (review)].
    Fiala J
    Vnitr Lek; 1986 Feb; 32(2):173-9. PubMed ID: 3962198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Implementation of apparative hemapheresis for collecting blood component stores. Recommendations of the Hemapheresis Commission of the German Society of Transfusion Medicine and Immunohematology].
    Kretschmer V; Borberg H; Giannitsis D; Kamanabroo D; Mempel W; Müller V; Müller N; Neumeyer H
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():57-64. PubMed ID: 3679531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychophysiological thrombocyte changes in cell-separator donors].
    Aulmann HM; Baltrusch HJ; Stangel W; Waltz EM
    Beitr Infusionther Klin Ernahr; 1987; 18():227-9. PubMed ID: 3439979
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safety and discomfort of the donors during thrombocytapheresis with the cell separator. A psychological study].
    Basler HD; Steinfelder C; Hartnack U; Kretschmer V
    Beitr Infusionther Klin Ernahr; 1987; 18():199-204. PubMed ID: 3439973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isolation of therapeutic doses of leukocytes and thrombocytes using a blood cell separator].
    Bláha M; Vanasek J; Malý J; Siroký O; Pecka M
    Gematol Transfuziol; 1983 Oct; 28(10):23-5. PubMed ID: 6654008
    [No Abstract]   [Full Text] [Related]  

  • 12. [Particle formation in disposable systems for the V.50.1 (Haemonetics) cell separator].
    Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1991; 28():159-61. PubMed ID: 1725614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocytapheresis with the new PLT-30 collection chamber in the CS 3000 Plus cell separator].
    Moog R; Müller N
    Beitr Infusionsther Transfusionsmed; 1994; 32():323-4. PubMed ID: 9480118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selection of donors in multicomponent collection management.
    Bonomo P; Garozzo G; Bennardello F
    Transfus Apher Sci; 2004 Feb; 30(1):55-9. PubMed ID: 14746822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of platelet concentrate yield in continuous-flow cell separation devices.
    Hester JP; Ventura GJ
    J Clin Apher; 1988; 4(4):188-93. PubMed ID: 3220820
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
    Wassmann A; Aulmann HM; Stangel W; Meinicke K
    Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
    [No Abstract]   [Full Text] [Related]  

  • 17. Positive selection of CD34+ cells by immune affinity.
    Höcker P; Kührer I; Worel N; Leitner G; Kalhs P; Greinix H; Gerhartl K
    Beitr Infusionsther Transfusionsmed; 1997; 34():166-70. PubMed ID: 9356669
    [No Abstract]   [Full Text] [Related]  

  • 18. Multicomponent collection (MCC) with the latest hemapheresis apparatuses.
    Valbonesi M; Florio G; Ruzzenenti MR; Bo A; Bruni R; Giannini G; Morelli F
    Int J Artif Organs; 1999 Jul; 22(7):511-5. PubMed ID: 10493560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell transplantation: approaches to an optimal blood stem cell collection.
    Coffe C; Couteret Y; Devillers M; Fest T; Morel P; Pouthier-Stein F; Calot JP; Novakovitch G; Sitthy X; Tremisi PJ
    Transfus Sci; 1992; 13(4):387-98. PubMed ID: 10147737
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].
    Budde U
    Beitr Infusionther Klin Ernahr; 1986; 15():75-81. PubMed ID: 3092802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.